Press releases | Finanzwire

Basculer en Français

8211	Companies
110016	Keywords
52013	Articles
60509	Press releases

Home
Press releases

PRESS RELEASE

published on 07/11/2024 at 07:30, 3 months 26 days ago

Gerresheimer Remains on Track in 1st Half Year 2024
Gerresheimer reports 1.7% revenue growth and 2.9% adjusted EBITDA increase in 1st half 2024, with Plastics & Devices division showing dynamic growth and improved margin

Revenue Growth Gerresheimer Adjusted EBITDA Increase Plastics & Devices Division Guidance Confirmed
PRESS RELEASE

published on 07/11/2024 at 07:30, 3 months 26 days ago

Inside Information / Other news releases
GenSight Biologics launches a newsletter for retail investors providing updates, news articles, conferences, and financial figures in French, available via subscription on the company's website

Subscription Retail Investors Newsletter French GenSight Biologics
PRESS RELEASE

published on 07/11/2024 at 07:29, 3 months 26 days ago

Fielmann Group grows HY1/2024 sales +12% over 2023, improves profitability
Fielmann Group reports 12% sales growth in HY1/2024, with improved profitability and outlook for Vision 2025. Digitalization and international expansion drive growth

Profitability Digitalization Fielmann Group HY1/2024 Sales Vision 2025
PRESS RELEASE

published on 07/11/2024 at 07:15, 3 months 26 days ago

Inside Information / Other news releases
Eurofins provides update to key stakeholders on actions responding to Muddy Waters' reports and plans for related party transactions. Additionally, the company addresses cash accounting and corporate governance

Corporate Governance Muddy Waters Related Party Transactions Stakeholders Eurofins
PRESS RELEASE

published on 07/11/2024 at 07:05, 3 months 26 days ago

Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation

Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation
REGULATED PRESS RELEASE

published on 07/11/2024 at 07:01, 3 months 26 days ago

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA

Biophytis FDA Approval Obesity Treatment BIO101 Phase 2 OBA Study
PRESS RELEASE

published on 07/11/2024 at 07:00, 3 months 26 days ago

Gerresheimer remains on track in 1st half year 2024
Gerresheimer remains on track with 1.7% revenue growth and 2.9% EBITDA increase in the 1st half of 2024. Plastics & Devices division shows good revenue growth and improved margin. Forecast for 2024 and 2025 confirmed

EBITDA Revenue Growth Forecast Gerresheimer 1st Half Year 2024
PRESS RELEASE

published on 07/11/2024 at 06:58, 3 months 26 days ago

DocMorris with accelerated and significant eRx growth in new customers, market share and revenue
DocMorris reports accelerated eRx growth in new customers, market share, and revenue, with significant progress in eRx business and expanding customer base

Revenue Market Share DocMorris ERx Growth CardLink
PRESS RELEASE

published on 07/11/2024 at 03:00, 3 months 26 days ago

Charting the Future of Nutrition: Mission Hill Foods Expands Research and Strengthens Market Presence in North America
Mission Hill Foods invests in advanced research, dev, & sustainable practices for consumer health, expanding its capabilities & initiatives in North America

North America Research Development Sustainable Practices Mission Hill Foods
PRESS RELEASE

published on 07/11/2024 at 01:55, 3 months 26 days ago

Organto Provides Bi-Weekly Update on Filing of 2023 Annual Financial Statements and Status of MCTO
Organto Foods Inc. provides update on management cease trade order for late filing of annual financial statements. Company and auditors working to complete filings

Business Update Management Cease Trade Order Annual Financial Statements Organto Foods Inc. Organic Products

Accesswire

Published on 11/06/2024 at 10:00, 35 minutes ago

BluSky Carbon Joint Venture Inks Binding LOI's for Biochar Projects in Orlando and Tanzania
Published on 11/06/2024 at 06:55, 3 hours 40 minutes ago

The Melrose Ventures Group Makes Take-Over Bid on Hank Payments Corp
Published on 11/06/2024 at 05:45, 4 hours 50 minutes ago

The Melrose Ventures Group Issues Early Warning Report
Published on 11/05/2024 at 23:05, 11 hours 30 minutes ago

BlackBerry to Participate in Upcoming Investor Events
Published on 11/05/2024 at 23:00, 11 hours 35 minutes ago

NXT Energy Solutions Announces The Award Of An SFD(R) Survey Contract

View all ACCESSWIRE

EQS Group

Published on 11/06/2024 at 10:15, 20 minutes ago

ROEMER CAPITAL INVITES CERTAIN HOLDERS TO TENDER TCS GROUP HOLDING PLC GDR (ISIN: US87238U2033, Bloomberg: TCS LI)
Published on 11/06/2024 at 10:02, 32 minutes ago

Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
Published on 11/06/2024 at 10:00, 35 minutes ago

Asklepios places its first Social Schuldschein loan of EUR 500.0 million
Published on 11/06/2024 at 10:00, 35 minutes ago

bet-at-home.com AG: Group figures for the first three quarters of 2024
Published on 11/06/2024 at 09:30, 1 hour 5 minutes ago

EQS-Adhoc: STEMMER IMAGING: Delisting Agreement concluded for delisting and receipt of request for negotiations of a domination and profit and loss transfer agreement

Les Echos

Published on 11/06/2024 at 08:05, 2 hours 30 minutes ago

Imerys-press-release-TalcUS-06-11-2024-VENG
Published on 11/06/2024 at 07:00, 3 hours 34 minutes ago

EURAZEO RECORDS DYNAMIC ASSET MANAGEMENT GROWTH AND A PICK-UP IN REALIZATIONS IN THE FIRST 9 MONTHS OF 2024, IN LINE WITH ITS STRATEGIC PLAN
Published on 11/05/2024 at 20:22, 14 hours 12 minutes ago

Disclosure of voting rights - 05.11.2024
Published on 11/05/2024 at 17:40, 16 hours 55 minutes ago

Eiffage wins in consortium the global public performance contract for the university areas of the Grand Paris Nord campus in Saint-Ouen-sur-Seine
Published on 11/05/2024 at 17:38, 16 hours 57 minutes ago

Neoen reports revenue in line with its expectations

View all LES ECHOS COMFI WIRE